Reduced beta2-glycoprotein i protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Wang, Wei Lin ^a   Meng, Zhen Xing ^a   Zhou, Sai Jun ^a   Li, Chun Jun ^a   Chen, Rui ^a   Lv, Lin ^a   Ma, Ze Jun ^a   Yu, De Min ^a   Yu, Pei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Beta2 glycoprotein I; Foam cell; Ox LDL; Reduced beta2 glycoprotein I

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; BETA2 GLYCOPROTEIN 1; CASPASE 3; CASPASE 9; CD36 ANTIGEN; CHOLESTEROL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OIL; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SCAVENGER RECEPTOR BI; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; FOAM CELL; GENE EXPRESSION; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-GLYCOPROTEIN I; BIOLOGICAL TRANSPORT; CASPASES; CELL DIFFERENTIATION; CELL LINE; CHOLESTEROL; FOAM CELLS; GENE EXPRESSION REGULATION; LIPOPROTEINS; LIPOPROTEINS, LDL; MAP KINASE KINASE 4; MICE; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION;

EID: 84887517849     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-174     Document Type: Article

References (34)

1. Macrophage differentiation to foam cells. Shashkin P, Dragulev B, Ley K, Curr Pharm Des 2005 11 23 3061 3072 10.2174/1381612054865064 16178764 (Pubitemid 41158090)
2. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. Feng B, Tabas I, J Biol Chem 2002 277 45 43271 43280 10.1074/jbc.M207532200 12215451 (Pubitemid 35285714)
3. Role of ABCG1 and other ABCG family members in lipid metabolism. Schmitz G, Langmann T, Heimerl S, J Lipid Res 2001 42 10 1513 1520 11590207 (Pubitemid 33020084)
4. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL, Cell Metab 2006 4 3 211 221 10.1016/j.cmet.2006.06.007 16950138 (Pubitemid 44283954)
5. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL, J Biol Chem 1999 274 27 19055 19062 10.1074/jbc.274.27.19055 10383407 (Pubitemid 29314101)
6. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Connelly MA, Williams DL, Curr Opin Lipidol 2004 15 3 287 295 10.1097/00041433-200406000-00008 15166784 (Pubitemid 38716561)
7. Current concepts on the pathogenesis of the antiphospholipid syndrome. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA, Blood 2007 109 2 422 430 10.1182/blood-2006-04-001206 16985176 (Pubitemid 46105935)
8. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. Bouma B, de Groot PG, van den Elsen JM, Ravelli RB, Schouten A, Simmelink MJ, Derksen RH, Kroon J, Gros P, Embo J 1999 18 19 5166 5174 10.1093/emboj/18.19.5166 10508150 (Pubitemid 29465567)
9. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM, Laggner P, Prassl R, Embo J 1999 18 22 6228 6239 10.1093/emboj/18.22.6228 10562535 (Pubitemid 29533227)
10. Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, Qi M, Yu P, Yu DM, Hogg PJ, et al. Blood 2010 116 11 1961 1970 10.1182/blood-2009-04-215335 20551379
11. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, et al. Blood 2010 116 11 1995 1997 10.1182/blood-2010-02-271494 20847215
12. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. George J, Harats D, Gilburd B, Afek A, Levy Y, Schneiderman J, Barshack I, Kopolovic J, Shoenfeld Y, Circulation 1999 99 17 2227 30 10.1161/01.CIR.99.17.2227 10226085 (Pubitemid 29201126)
13. Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (beta2-glycoprotein I). Lin KY, Pan JP, Yang DL, Huang KT, Chang MS, Ding PY, Chiang AN, Life Sci 2001 69 6 707 719 10.1016/S0024-3205(01)01164-X 11476192 (Pubitemid 32673629)
14. beta(2)-glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis. Lin KY, Wang HH, Lai ST, Pan JP, Chiang AN, J Cell Biochem 2005 94 3 485 496 10.1002/jcb.20314 15534879 (Pubitemid 41420286)
15. Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells. Liu Q, Dai Z, Liu Z, Liu X, Tang C, Wang Z, Yi G, Liu L, Jiang Z, Yang Y, et al. Acta Biochim Biophys Sin (Shanghai) 2010 42 9 635 645 10.1093/abbs/gmq070 20710016
16. Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression. Yao S, Zong C, Zhang Y, Sang H, Yang M, Jiao P, Fang Y, Yang N, Song G, Qin S, J Atheroscler Thromb 2013 20 1 94 107 10.5551/jat.13425 23037953
17. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA, Proc Natl Acad Sci USA 1980 77 4 2214 2218 10.1073/pnas.77.4.2214 6769124 (Pubitemid 10089629)
18. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. Yu P, Passam FH, Yu DM, Denyer G, Krilis SA, J Thromb Haemost 2008 6 7 1215 1223 10.1111/j.1538-7836.2008.03000.x 18452581 (Pubitemid 351859131)
19. beta(2)-Glycoprotein I inhibits endothelial cell migration through the nuclear factor kappaB signalling pathway and endothelial nitric oxide synthase activation. Chiu WC, Chiou TJ, Chiang AN, Biochem J 2012 445 1 125 133 10.1042/BJ20111383 22489810
20. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis. Lopez LR, Kobayashi K, Matsunami Y, Matsuura E, Clin Rev Allergy Immunol 2009 37 1 12 19 10.1007/s12016-008-8096-8 18982458
21. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Foteinos G, Xu Q, Autoimmunity 2009 42 7 627 633 10.1080/08916930903002529 19863380
22. Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus. Zhang C, Li K, Shi B, Wang X, Liu X, Qin W, Han A, Wang J, Clin Chim Acta 2010 411 5-6 395 399 20026018
23. C-reactive protein/oxidised low-density lipoprotein/beta2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway. Zhang R, Zhou SJ, Li CJ, Wang XN, Tang YZ, Chen R, Lv L, Zhao Q, Xing QL, Yu DM, et al. Lipids Health Dis 2013 12 42 10.1186/1476-511X-12-42 23531147
24. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. Kobayashi K, Kishi M, Atsumi T, Bertolaccini ML, Makino H, Sakairi N, Yamamoto I, Yasuda T, Khamashta MA, Hughes GR, et al. J Lipid Res 2003 44 4 716 726 10.1194/jlr.M200329-JLR200 12562869 (Pubitemid 37279673)
25. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus. Lopez LR, Hurley BL, Simpson DF, Matsuura E, Ann N Y Acad Sci 2005 1051 97 103 10.1196/annals.1361. 050 16126948 (Pubitemid 41362736)
26. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y, Lupus 2005 14 9 736 741 10.1191/0961203305lu2211oa 16218478 (Pubitemid 41413302)
27. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, et al. Arthritis Rheum 2011 63 9 2774 2782 10.1002/art.30383 21618459
28. Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, et al. J Thromb Haemost 2010 8 8 1754 1762 10.1111/j.1538-7836.2010.03944.x 20979592
29. Apoptosis in atherosclerosis: beneficial or detrimental? Kockx MM, Herman AG, Cardiovasc Res 2000 45 3 736 746 10.1016/S0008-6363(99)00235-7 10728396 (Pubitemid 30047141)
30. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. Seimon T, Tabas I, J Lipid Res 2009 50 Suppl 382 S387 18953058
31. JNK signaling in apoptosis. Dhanasekaran DN, Reddy EP, Oncogene 2008 27 48 6245 6251 10.1038/onc.2008.301 18931691
32. p38 MAPK plays an essential role in apoptosis induced by photoactivation of a novel ethylene glycol porphyrin derivative. Kralova J, Dvorak M, Koc M, Kral V, Oncogene 2008 27 21 3010 3020 10.1038/sj.onc.1210960 18059338 (Pubitemid 351668007)
33. Caspases and kinases in a death grip. Kurokawa M, Kornbluth S, Cell 2009 138 5 838 854 10.1016/j.cell.2009.08.021 19737514
34. Quantitative determination of cholesterol, sitosterol, and sitostanol in cultured Caco-2 cells by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Palmgren JJ, Toyras A, Mauriala T, Monkkonen J, Auriola S, J Chromatogr B Analyt Technol Biomed Life Sci 2005 821 2 144 152 10.1016/j.jchromb.2005.04.029 15914100 (Pubitemid 40827020)